关键词: 血脂, 脂蛋白, 血脂管理, 动脉粥样硬化性心血管疾病

Abstract:

Dyslipidemia，especially elevated low-density lipoprotein cholesterol （LDL-C），is a pathogenic risk factor for atherosclerotic cardiovascular disease （ASCVD）. As the primary link in blood lipid management，the quality of clinical blood lipid testing directly determines the accuracy of clinical decision-making for ASCVD and the overall level of comprehensive management. Therefore，it is recommended to conduct comprehensive and systematic quality management throughout the blood lipid testing process，including pre-examination processes，examination processes and post-examination processes，so as to promote the standardization of clinical blood lipid profile testing and provide reliable support for precise blood lipid management across the whole life cycle. Meanwhile，further communication between clinical laboratories and clinical departments should be strengthened to comprehensively improve the quality of clinical blood lipid management.

Key words: Blood lipid, Lipoprotein, Blood lipid management, Atherosclerotic cardiovascular disease